Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Surgically menopausal women are at increased risk for low sexual desire

Researchers have published the first-ever multi-cultural prevalence study using multi-dimensional psychometrically valid outcomes to determine if women who undergo surgical menopause have a greater risk of low sexual interest compared with that of pre-menopausal or naturally menopausal women.

1 Mar 2006

Studies examine links between provider characteristics and mortality rates in ovarian cancer

Two studies in the Journal of the National Cancer Institute examine whether hospital volume, surgeon experience, or surgeon specialty affect the treatment received and the risk of death following treatment among women with ovarian cancer.

24 Feb 2006

Ovarian cancer responds to aspirin and chemotherapy drug cisplatin

A new study using ovarian cancer cell lines shows promise in treating the deadly disease by combining the chemotherapy drug cisplatin with an aspirin-like compound to make recurrent cancer cells less resistant to the chemotherapy.

17 Feb 2006

BRCA1 gene inhibits estrogen and progesterone

It's been known that the breast cancer susceptibility gene BRCA1 regulates use of estrogen in breast and other cells, but now researchers at Georgetown University Medical Center have discovered that it also controls activity of a second sex steroid hormone, progesterone.

27 Jan 2006

TCF21 gene shown to be a tumor suppressor

Researchers have identified a new and unusual tumor suppressor gene that may be important in cancers of the lung and head and neck. The study shows that restoring the inactivated gene can slow the growth of tumor cells.

18 Jan 2006

Abdominal chemotherapy boosts survival in ovarian cancer patients

Women with Stage III ovarian cancer given a combination of intravenous and intraperitoneal chemotherapy following surgical debulking of tumor had a median survival nearly 16 months longer than women who received IV chemotherapy alone

10 Jan 2006

Intraperitoneal chemotherapy prolongs survival for women with advanced ovarian cancer

A study featured in this month's edition of Gynecologic Oncology examines the challenges associated with the administration of intra-abdominal chemotherapy, also known as intraperitoneal (IP) chemotherapy.

8 Jan 2006

Anti-cancer drugs based on platinum

Researchers at Virginia Commonwealth University's Massey Cancer Center have created a new platinum-based, anti-cancer agent able to overcome acquired drug resistance by first modifying the way it is absorbed into cancer cells and then attacking the DNA of those cancer cells.

6 Jan 2006

Delivering chemotherapy directly into the abdomen boosts survival in ovarian cancer patients

A 50-year-old method for delivering chemotherapy directly into the abdomen is making a comeback as investigators have found that it increases survival - by more than a year - in some women with advanced ovarian cancer. Results from a seven-year study of more than 400 patients nationwide are published in the New England Journal of Medicine.

6 Jan 2006

Daily dose of Vitamin D cuts cancer risk

According to cancer prevention specialists, taking vitamin D3 daily appears to lower the risk of cancer by up to as much 50 percent.

28 Dec 2005

65% of ovarian cancer cells sideline body's defences

Ovarian cancer tumour cells use two separate mechanisms to evade the body’s defensive reaction - and in so doing also elude a newly discovered counteraction from the surrounding tissue.

15 Dec 2005

Gene mapping project promises new targeted cancer therapies

Government researchers in the United States have this week launched a pilot project to find all the little genetic changes that cause cancer in the hope it will lead to a whole new world of targeted cancer therapy.

14 Dec 2005

Tea lowers ovarian cancer risk

Women who drank at least two cups of tea a day had a lower risk of ovarian cancer than those who did not drink tea, according to a study in the December 12/26 issue of Archives of Internal Medicine.

13 Dec 2005

A cuppa a day keeps cancer away

According to a Swedish study, women who drink two or more cups of tea per day may dramatically cut their risk of ovarian cancer.

12 Dec 2005

Phenoxodiol - docetaxel combination for women with recurrent ovarian cancer

A clinical study of ovarian cancer initiated by investigators at Yale School of Medicine will combine the anti-cancer drug phenoxodiol with docetaxel for women with recurrent ovarian cancer.

5 Dec 2005

Genetic profile of ovarian cancer

A newly identified gene expression profile could help predict how patients with advanced ovarian cancer will respond to chemotherapy treatment.

7 Nov 2005

Lack of gene expression associated with ovarian cancer

The expression of two specific genes is almost completely downregulated in ovarian cancer tumours. An extensive analysis of gene expression in ovarian cancer tumour cells has revealed this important finding, which should be an aid to early diagnosis.

24 Oct 2005

Access to genetic counseling and testing are an important part of cancer control

Ten years after the identification of the first breast cancer susceptibility genes so few high-risk minority women have received genetic counseling or testing that the standard methods of calculating risk have not been validated in these groups and the results of genetic testing can still produce surprises.

18 Oct 2005

Data supports use of personal and family history of breast cancer, ovarian cancer, or both in making clinical decisions

African American women at high-risk of breast cancer have genetic mutations that would make genetic testing feasible, according to a study in the October 19 issue of JAMA: The Journal of the American Medical Association.

18 Oct 2005

Removing metastatic disease from the diaphragm significantly increases survival rates in ovarian cancer patients

In a retrospective study looking back at a decade of surgeries, Mayo Clinic Cancer Center researchers have determined that surgery to remove metastatic disease from the diaphragm, in conjunction with other procedures to remove the primary diseased tissue in ovarian cancer patients, significantly increases survival rates.

12 Oct 2005

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Surgically menopausal women are at increased risk for low sexual desire

Studies examine links between provider characteristics and mortality rates in ovarian cancer

Ovarian cancer responds to aspirin and chemotherapy drug cisplatin

BRCA1 gene inhibits estrogen and progesterone

TCF21 gene shown to be a tumor suppressor

Abdominal chemotherapy boosts survival in ovarian cancer patients

Intraperitoneal chemotherapy prolongs survival for women with advanced ovarian cancer

Anti-cancer drugs based on platinum

Delivering chemotherapy directly into the abdomen boosts survival in ovarian cancer patients

Daily dose of Vitamin D cuts cancer risk

65% of ovarian cancer cells sideline body's defences

Gene mapping project promises new targeted cancer therapies

Tea lowers ovarian cancer risk

A cuppa a day keeps cancer away

Phenoxodiol - docetaxel combination for women with recurrent ovarian cancer

Genetic profile of ovarian cancer

Lack of gene expression associated with ovarian cancer

Access to genetic counseling and testing are an important part of cancer control

Data supports use of personal and family history of breast cancer, ovarian cancer, or both in making clinical decisions

Removing metastatic disease from the diaphragm significantly increases survival rates in ovarian cancer patients

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in